Real-time enrollment status for this end stage kidney disease clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 6:34 AM UTC
| NCT Number | NCT05485961 |
| Recruiting Status | Recruiting |
| Condition | End Stage Kidney Disease |
| Phase | Clinical Trial |
| Target Enrollment | 2,310 participants |
| Active Locations | 145 sites in the US |
| Sponsor | CSL Behring |
| Last Updated on CT.gov | April 9, 2026 (1 week ago) |
As of April 17, 2026: Clinical trial NCT05485961 is currently recruiting participants. This clinical trial study for end stage kidney disease is actively seeking new participants at 145 locations across the United States. The study is sponsored by CSL Behring. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05485961 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 145 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05485961 was last updated 1 week ago (April 9, 2026). HelloStudys verifies this status automatically.